Revisiting dexamethasone dosage in COVID-19 management

doi:10.5501/wjv.v14.i1.98359

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (116)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

HTML

Sum=95

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=14

Mar 25, 2025 (publication date) through Dec 4, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Virology

ISSN

2220-3249

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Letter to the Editor

World J Virol. Mar 25, 2025; 14(1): 98359
Published online Mar 25, 2025. doi: 10.5501/wjv.v14.i1.98359

Revisiting dexamethasone dosage in COVID-19 management

Abhishet Varama

Abhishet Varama, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Krung Thep Maha Nakhon, Thailand

Author contributions: Abhishet V drafted, wrote and edited the editorial. No external help was used in the making of this manuscript.

Conflict-of-interest statement: The author declares no conflict of interest associated with this manuscript.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Abhishet Varama, BSc, Master's Student, Faculty of Medicine, Chulalongkorn University, 1873 Rama IV Road, Pathum Wan, Bangkok 10330, Krung Thep Maha Nakhon, Thailand. abhishet.varama@docchula.com

Received: June 25, 2024
Revised: November 18, 2024
Accepted: November 26, 2024
Published online: March 25, 2025
Processing time: 155 Days and 22 Hours

Core Tip

Core Tip: This editorial delves into the critical analysis provided by Sethi et al on dexamethasone dosing in severe coronavirus disease 2019 (COVID-19) cases. Highlighting the review's challenge to the one-size-fits-all approach, it emphasizes the need for personalized medicine and calls for further research to refine treatment protocols based on emerging evidence and patient-specific factors. The editorial advocates for the integration of nuanced clinical data to enhance therapeutic strategies against COVID-19, fostering a broader discussion on the adaptability of clinical practice in pandemic responses and the potential for tailored patient care.